Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Robert Burakoff, M.D.

Co-Author

This page shows the publications co-authored by Robert Burakoff and Frederick Makrauer.
Connection Strength

0.509
  1. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015 May; 21(5):1132-40.
    View in: PubMed
    Score: 0.158
  2. Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea. Inflamm Bowel Dis. 2011 Aug; 17(8):1719-25.
    View in: PubMed
    Score: 0.117
  3. Differential regulation of peripheral leukocyte genes in patients with active Crohn's disease and Crohn's disease in remission. J Clin Gastroenterol. 2010 Feb; 44(2):120-6.
    View in: PubMed
    Score: 0.110
  4. High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease. Inflamm Bowel Dis. 2014 Sep; 20(9):1602-10.
    View in: PubMed
    Score: 0.038
  5. Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Mar; 19(3):534-9.
    View in: PubMed
    Score: 0.034
  6. Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer. Inflamm Bowel Dis. 2012 Aug; 18(8):1531-9.
    View in: PubMed
    Score: 0.031
  7. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis. 2006 Apr; 12(4):251-7.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.